New computer system enables hospital staff to overcome potential for human
error and increase transfusion safety.
LENEXA, Kan., May 27 /PRNewswire-FirstCall/ -- Mediware Information Systems (Nasdaq: MEDW), http://www.mediware.com, a provider of ClosedLoop(TM) clinical systems for blood and medication management, said today that All Children's Hospital of St. Petersburg, Fla., has completed its validation of label scanning and printing with Mediware's HCLL blood management software. The validation allowed the hospital to achieve compliance with standards of the International Society for Blood Transfusion (ISBT) for labeling and processing blood products.
All Children's is the only freestanding children's hospital on the west coast of Florida. A referral center that draws children throughout the state with challenging medical problems, All Children's has been rated in the Top 25 children's hospitals by Child magazine.
"We were relieved to go live with ISBT compliance before the deadline," said Dee McMichael, blood bank supervisor for All Children's. McMichael added that going live three weeks before the ISBT deadline provided ample time to train nurses, doctors and transfusionists on the system. "We had the opportunity to ask questions and share experiences with Mediware before we started receiving ISBT coded blood products,' she said.
McMichael noted an essential feature of HCLL for All Children's is the ability to print full-faced 4x4 ISBT labels directly from the system. "Because we do so much component processing, there would be huge safety issues if we had to print labels separately," she explained. "The potential for human error in printing labels is eliminated with HCLL."
"We are very confident our software has All Children's Hospital and other customers well positioned to transition to ISBT 128, and we have worked feverishly to support our customers as they comply with this important global labeling standard for blood and biologics management," said John Damgaard, senior vice president and chief operating officer at Mediware. He added that 12 to 15 Mediware customers go live every quarter on HCLL software that is already ISBT compliant.
Blood centers and hospitals that did not implement systems that fulfill ISBT requirements by the May 1 deadline must file with the American Association of Blood Banks (AABB) and have a variance approved which documents when the facility will have the necessary systems in place. "For facilities that have not licensed our software or have been unable to meet the deadline, our product specialists are available to help," said Damgaard.
"Mediware has always been committed to providing its customers the safest blood management system in the industry," said Damgaard. "That commitment to safety continues in HCLL's ability to meet ISBT standards while at the same time increasing patient safety and reducing risk. HCLL has more built-in patient safety checks than any other transfusion system today," he added.
Implementing systems to support the new standard has been a long and difficult process for blood centers and hospitals. Mediware, which has been a market leader in blood management systems for more than 25 years, released a version of the LifeTrak software that addresses the ISBT standards in May 2007. Mediware's HCLL Transfusion product has addressed the ISBT standards since its inception and Mediware's BiologiCare(TM) biologics management platform will also fully support ISBT upon its commercial release in June 2008.
Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at http://www.mediware.com.
Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.
|SOURCE Mediware Information Systems|
Copyright©2008 PR Newswire.
All rights reserved